Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-28 5:33 pm Purchase | 2025-11-25 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 93,442,787 24.200% | 12,578,472 (+15.56%) | Filing History |
| 2025-11-14 5:14 pm Sale | 2025-09-30 | 13G | Codexis, Inc. CDXS | Casdin Capital, LLC | 0 0.000% | -7,200,000 (Position Closed) | Filing History |
| 2025-10-17 8:04 pm Sale | 2025-10-15 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 5,957,165 12.400% | -750,000 (-11.18%) | Filing History |
| 2025-08-21 9:35 pm Sale | 2025-08-15 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 6,707,165 14.000% | -500,000 (-6.94%) | Filing History |
| 2025-08-14 4:34 pm Sale | 2025-06-30 | 13G | Codexis, Inc. CDXS | Casdin Capital, LLC | 7,200,000 8.700% | -900,000 (-11.11%) | Filing History |
| 2025-08-13 7:00 pm Sale | 2025-08-11 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 7,207,165 15.000% | -500,000 (-6.49%) | Filing History |
| 2025-06-12 9:10 pm Sale | 2025-06-10 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 7,707,165 16.200% | -1,027,994 (-11.77%) | Filing History |
| 2025-05-15 4:27 pm Sale | 2025-03-31 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,212,316 3.700% | -1,380,000 (-30.05%) | Filing History |
| 2025-04-09 5:13 pm Purchase | 2025-04-07 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 8,735,159 18.500% | 27,994 (+0.32%) | Filing History |
| 2025-03-07 8:22 pm Purchase | 2025-03-04 | 13D | Tenaya Therapeutics, Inc. TNYA | Casdin Capital, LLC | 6,732,971 4.300% | 305,771 (+4.76%) | Filing History |
| 2025-03-04 7:46 pm Purchase | 2025-02-28 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 80,864,315 21.600% | 7,098,241 (+9.62%) | Filing History |
| 2025-02-14 4:00 pm Purchase | 2024-12-31 | 13G | Neurogene Inc. NGNE | Casdin Capital, LLC | 1,295,361 8.700% | 270,745 (+26.42%) | Filing History |
| 2024-11-27 6:51 pm Purchase | 2024-11-20 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 4,592,316 5.400% | 1,380,000 (+42.96%) | Filing History |
| 2024-11-14 4:08 pm Sale | 2024-09-30 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,212,316 3.800% | -1,978,190 (-38.11%) | Filing History |
| 2024-11-08 4:33 pm Purchase | 2024-11-04 | 13G | Neurogene Inc. NGNE | Casdin Capital, LLC | 1,024,616 6.900% | 1,024,616 (New Position) | Filing History |
| 2024-09-26 09:27 am Purchase | 2024-09-20 | 13G | Codexis, Inc. CDXS | Casdin Capital, LLC | 8,100,000 9.900% | 8,100,000 (New Position) | Filing History |
| 2024-08-14 8:54 pm Purchase | 2024-08-12 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 73,766,074 19.770% | 8,468,478 (+12.97%) | Filing History |
| 2024-06-03 5:20 pm Sale | 2024-05-30 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital, LLC | 70,401,337 18.910% | -5,936,401 (-7.78%) | Filing History |
| 2024-05-22 4:54 pm Purchase | 2024-05-17 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital, LLC | 76,337,738 20.370% | 1,802,072 (+2.42%) | Filing History |
| 2024-04-18 4:36 pm Purchase | 2024-04-11 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 5,190,506 6.080% | 1,984,126 (+61.88%) | Filing History |